GLAXOSMITHKLINE CARIBBEAN LIMITED - Profile & Financials

Accounts Submitted 14 Aug 2025

Confirmation Statement Submitted 4 Aug 2025

Net assets £37.59M £206.00K 2023 year on year

Total assets £41.22M £1.46M 2023 year on year

Total Liabilities £3.63M £1.66M 2023 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Office (Ware)

45 Priory St, Ware SG12 0DE

Office (Brentford, Middlesex, United Kingdom)

980 Great West Road, TW8 9GS

Telephone

+302106882100

contract.manufacturing@gsk.com

Website

gsk.com

Credit Report

Discover GLAXOSMITHKLINE CARIBBEAN LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£2.61M

Increased by £379.00k (+17%)

Net Assets

£37.59M

Decreased by £206.00k (-1%)

Total Liabilities

£3.63M

Increased by £1.66M (+85%)

Turnover

£16.52M

Decreased by £7.31M (-31%)

Employees

Debt Ratio

Increased by 4 (+80%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 29 resigned

Show resigned officers

						Status
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	15 Mar 2001	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	18 Jan 2002	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	15 Mar 2001	Active
Graham Paul Rivers	Director	British	United Kingdom	54	2 Mar 2020	Active

Shareholders

Shareholders (1)


Smithkline Beecham Limited	100.0%	5,300,000	Ordinary	26 Aug 2015

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Smithkline Beecham Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

SMITHKLINE BEECHAM LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

GLAXOSMITHKLINE CARIBBEAN LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
14 Aug 2025	Accounts	Annual accounts made up to 2024-12-31	View(25 pages)
4 Aug 2025	Confirmation Statement	Confirmation statement made on 2025-08-04 with no updates	View(3 pages)
17 Sept 2024	Officers	Change to director Mr Graham Paul Rivers on 2024-09-11	View(2 pages)
11 Sept 2024	Persons With Significant Control	Change to Smithkline Beecham Limited as a person with significant control on 2024-09-11	View(2 pages)
11 Sept 2024	Address	Change Registered Office Address Company With Date Old Address New Address	View(1 page)